Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases
1 other identifier
observational
600
1 country
1
Brief Summary
The goal of this observational study is to provide a reference for clinicians to conduct genetic counseling and carry out preimplantation genetic testing of mitochondrial patients. The main questions it aims to answer are:
- The relationship between mitochondrial mutation load and clinical symptom
- The symptomatic threshold of common mitochondrial DNA mutations
- The distribution of mitochondrial mutation load in offspring and genetic rule of mitochondrial DNA mutation
- The minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers Biological samples such as blood, urine, oral epithelial cells, nails, some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured. The clinical symptoms and mutation load of the participants will be followed up once a year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2024
CompletedFirst Posted
Study publicly available on registry
June 10, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
October 28, 2024
June 1, 2024
2 years
June 3, 2024
October 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptoms of mitochondrial disease
The enrolled patients were followed up once a year. Symptoms that the patient has due to mitochondrial DNA mutations are recorded.
3 years
Secondary Outcomes (2)
level of mitochondrial DNA mutation
3 years
Tissue-specific distribution of mitochondrial DNA mutation levels
When they enrolled
Interventions
Biological samples such as blood, urine, oral epithelial cells and nails of carriers were collected, and some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells were collected. Placenta and umbilical cord blood samples of some fetuses were collected after delivery, and the mitochondrial DNA mutation heterogeneity level was determined.
Eligibility Criteria
mtDNA mutation carriers from The First Affiliated Hospital of Anhui Medical University
You may qualify if:
- Clinical diagnosis of mitochondrial DNA diseases
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230022, China
Biospecimen
blood, urine, oral epithelial cells, fingernail, trophectoderm cells, embryo culture medium, amniotic fluid, placenta, granulosa cell
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dongmei Ji, Dr.
The First Affiliated Hospital of Anhui Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 3, 2024
First Posted
June 10, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
October 28, 2024
Record last verified: 2024-06